Evaluation of cholinesterase-restoring agents in the treatment of tetanus in man.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002746:Chlorpromazine / Q000627:therapeutic use; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D002802:Cholinesterases / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008698:Mesylates / Q000627:therapeutic use; D008875:Middle Aged; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D013742:Tetanus / Q000145:classification / Q000188:drug therapy* / Q000401:mortality; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D002801:Cholinesterase Reactivators; D008698:Mesylates; D011220:Pralidoxime Compounds; D013743:Tetanus Antitoxin; D010402:Penicillin G Procaine; D002802:Cholinesterases; D014805:Vitamin B 12; D002746:Chlorpromazine